Safety and Efficacy Clinical Study of KL-HIV-Tri01 in the Treatment of HIV Infected Subjects
Status:
Not yet recruiting
Trial end date:
2025-09-10
Target enrollment:
Participant gender:
Summary
This is an open- label, non- randomized, uncontrolled, dose-escalation pilot study to
evaluate the safety and efficacy of KL-HIV-Tri01 injection solution in HIV infected subjects
treated with HAART.
Phase:
Early Phase 1
Details
Lead Sponsor:
Affiliated Hospital of Guangdong Medical University